| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
207,851,000 |
| Market
Cap: |
11.18(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$32.18 - $59.82 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
1,000 |
1,000 |
| Total Buy Value |
$0 |
$0 |
$49,980 |
$49,980 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
387 |
387 |
11,063 |
116,582 |
| Total Sell Value |
$21,749 |
$21,749 |
$512,581 |
$11,151,362 |
| Total People Sold |
1 |
1 |
12 |
18 |
| Total Sell Transactions |
1 |
1 |
25 |
69 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dolan Christine |
SVP - Product Development |
• – – |
2017-08-29 |
4 |
OE |
$18.57 |
$169,916 |
D/D |
9,150 |
27,007 |
|
- |
|
| Gunther Scott |
SVP, Quality & Reg. Affairs |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$30,597 |
D/D |
(869) |
11,870 |
|
- |
|
| Gunther Scott |
SVP, Quality & Reg. Affairs |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,641 |
12,739 |
|
- |
|
| Walsh Matthew M |
EVP & Chief Financial Officer |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$290,306 |
D/D |
(8,245) |
103,703 |
|
- |
|
| Walsh Matthew M |
EVP & Chief Financial Officer |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
16,191 |
111,948 |
|
- |
|
| Gennadios Aristippos |
See Remarks |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$92,708 |
D/D |
(2,633) |
22,525 |
|
- |
|
| Gennadios Aristippos |
See Remarks |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
8,594 |
25,158 |
|
- |
|
| Downie William |
SVP, Global Sales & Marketing |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$198,725 |
D/D |
(5,644) |
41,925 |
|
- |
|
| Downie William |
SVP, Global Sales & Marketing |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,338 |
47,569 |
|
- |
|
| Miyamoto Lance |
SVP - Human Resources |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$126,897 |
D/D |
(3,604) |
33,797 |
|
- |
|
| Miyamoto Lance |
SVP - Human Resources |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,960 |
37,401 |
|
- |
|
| Dolan Christine |
SVP - Product Development |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$66,230 |
D/D |
(1,881) |
17,857 |
|
- |
|
| Dolan Christine |
SVP - Product Development |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,680 |
19,738 |
|
- |
|
| Fasman Steven L |
See Remarks |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$134,784 |
D/D |
(3,828) |
37,666 |
|
- |
|
| Fasman Steven L |
See Remarks |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
11,131 |
41,494 |
|
- |
|
| Joseph Wetteny |
President - CSS |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$64,153 |
D/D |
(1,822) |
14,277 |
|
- |
|
| Joseph Wetteny |
President - CSS |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,541 |
16,099 |
|
- |
|
| Maselli Alessandro |
SVP - Global Operations |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$25,281 |
D/D |
(718) |
13,603 |
|
- |
|
| Maselli Alessandro |
SVP - Global Operations |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,519 |
14,321 |
|
- |
|
| Chiminski John R |
President & CEO |
• • – |
2017-08-24 |
4 |
D |
$35.21 |
$685,609 |
D/D |
(19,472) |
355,724 |
|
- |
|
| Chiminski John R |
President & CEO |
• • – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
42,320 |
365,454 |
|
- |
|
| Littlejohns Barry |
President - DDS |
• – – |
2017-08-24 |
4 |
D |
$35.21 |
$119,714 |
D/D |
(3,400) |
32,249 |
|
- |
|
| Littlejohns Barry |
President - DDS |
• – – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,338 |
35,649 |
|
- |
|
| Lucier Gregory T |
Director |
– • – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,976 |
32,639 |
|
- |
|
| Roehrhoff Uwe |
Director |
– • – |
2017-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,976 |
8,989 |
|
- |
|
821 Records found
|
|
Page 26 of 33 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.18 (0.34%) 
